Prat, A
Lluch, A
Albanell, J
Barry, W T
Fan, C
Chacón, J I
Parker, J S
Calvo, L
Plazaola, A
Arcusa, A
Seguí-Palmer, M A
Burgues, O
Ribelles, N
Rodriguez-Lescure, A
Guerrero, A
Ruiz-Borrego, M
Munarriz, B
López, J A
Adamo, B
Cheang, M C U
Li, Y
Hu, Z
Gulley, M L
Vidal, M J
Pitcher, B N
Liu, M C
Citron, M L
Ellis, M J
Mardis, E
Vickery, T
Hudis, C A
Winer, E P
Carey, L A
Caballero, R
Carrasco, E
Martín, M
Perou, C M
Alba, E
Article History
Received: 6 April 2014
Revised: 26 June 2014
Accepted: 13 July 2014
First Online: 7 August 2014
Competing interests
: CMP and MJE are equity stock holders of BioClassifier LLC and University Genomics. CMP, MJE, MCUC and JSP have filed a patent on the PAM50 assay. MLG serves as a consultant for Roche Molecular Systems. Uncompensated advisory role of AP for Nanostring Technologies. The remaining authors declare no conflict of interest.